Sentences with phrase «focusing on cancer treatment»

For example, MethylGene Inc. (TSX: MYG) is focusing on cancer treatment, biOasis Technologies Inc. (TSXV: BTI) is pursuing research on disorders of the central nervous system, and Cipher Pharmaceuticals Inc. (TSX: DND) is working on a treatment for acne - related conditions.

Not exact matches

Shares of cancer - focused biotech Clovis Oncology soared nearly 50 % in early Monday trading on the strength of clinical trial results for its ovarian cancer treatment Rubraca.

A great example of this is a health - care organization called TGEN, which is focused on developing ways to diagnose cancer earlier and provide smarter treatments for patients.

• RefleXion, a Hayward, Calif. - based cancer treatment firm focused on positron emission tomography, closed $ 100 million in Series C funding.

Biotech giant Gilead Sciences is beefing up its cancer drug portfolio with a $ 11.9 billion deal to buy Kite Pharma, a company focused on a groundbreaking new class of treatments that turns the body's own immune cells into targeted blood cancer killers.

So, Loncar took matters into his own hands and created a new type of biotech index that focuses exclusively on the red - hot field of cancer immunotherapy drugs (treatments which use the body's immune system as a conduit to fight cancer).

Sierra Oncology, Inc., a clinical stage drug development company focused on advancing next - generation DNA damage response therapeutics for the treatment of patients with cancer, went public near $ 29 in July 2015, then began a downtrend that continued through a June 2017 all - time low of $ 1.10.

She has a particular focus on breast cancer research and treatment, and in 2015, she donated $ 25 million to this area.

We can focus on what we truly want to do, whether that is discovering the next new cancer treatment, developing the most competitive solar panels, or working on the latest computer chip technology.

Macrogenics, a biopharmaceutical company, is focused on discovering and developing innovative antibody - based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases.

While previous studies have surveyed the genomic characteristics of tumors confined to the prostate gland, the new study is the first to focus on metastatic hormone resistant prostate cancers, which can be difficult to treat because they often develop resistance to standard treatments.

Precision cancer care focuses on identifying the specific biomarkers of a patient's cancer, which can help doctors make decisions about the best treatment options.

For this study, Dr. Lou and his colleagues focused on triple - negative breast cancer, which is difficult to treat, because it does not exhibit receptors for estrogen, progesterone or the HER - 2 / neu gene, which are targets for many current breast cancer treatments.

The article focuses mainly on patients with cancer, who often undergo treatments that can cause profound alterations in the gut microbiota and potentially contribute to the development of complications.

«Funding research focused on helping patients survive longer is critical, and studies such as this advance our goal of not only improving treatments for brain cancer, but eventually finding a cure.»

This discovery is in line with the recent advances in cancer immunotherapy, a field that focuses on the design of treatments based on the human immune system.

«Other studies have looked at racial disparities in treatment and still others have focused on racial differences in survival rates of cancer patients, but our research attempted to go further by demonstrating the impact of race - based inequalities in cancer treatment on survival rates of black colorectal cancer patients,» said James D. Murphy, MD, MS, assistant professor and chief of the Radiation Oncology Gastrointestinal Tumor Service at UC San Diego Moores Cancer Ccancer patients, but our research attempted to go further by demonstrating the impact of race - based inequalities in cancer treatment on survival rates of black colorectal cancer patients,» said James D. Murphy, MD, MS, assistant professor and chief of the Radiation Oncology Gastrointestinal Tumor Service at UC San Diego Moores Cancer Ccancer treatment on survival rates of black colorectal cancer patients,» said James D. Murphy, MD, MS, assistant professor and chief of the Radiation Oncology Gastrointestinal Tumor Service at UC San Diego Moores Cancer Ccancer patients,» said James D. Murphy, MD, MS, assistant professor and chief of the Radiation Oncology Gastrointestinal Tumor Service at UC San Diego Moores Cancer CCancer Center.

She helped lead a GSK project focused on designing a monoclonal antibody to link to the HER3 receptor on human cells as a treatment for cancer.

Maggie Blanks, Pancreatic Cancer Research Fund's CEO, said: «It's because of these bleak facts that our funding strategy focuses on finding and developing alternative, effective treatments for patients as well as finding a way to diagnose pancreatic cancer at an early Cancer Research Fund's CEO, said: «It's because of these bleak facts that our funding strategy focuses on finding and developing alternative, effective treatments for patients as well as finding a way to diagnose pancreatic cancer at an early cancer at an early stage.

As we are seeing more women survive breast cancer, we need to focus on long term survivorship issues and ensuring that women have access to this important part of treatment,» says study first author Reshma Jagsi, M.D., D.Phil., associate professor of radiation oncology at the University of Michigan Comprehensive Cancer Ccancer, we need to focus on long term survivorship issues and ensuring that women have access to this important part of treatment,» says study first author Reshma Jagsi, M.D., D.Phil., associate professor of radiation oncology at the University of Michigan Comprehensive Cancer CCancer Center.

This webinar is the first in a series (see Part 2 here) focusing on the pathways that allow for cancer development and progression, the emerging research in identifying and targeting these pathways, and the innovations in the development of cancer treatment options.

«There's an increasingly recognized focus on the holistic treatment of cancer patients.

«Current cancer treatment often focuses on targeting cancer cells, but is not focused on targeting the fibrotic connective tissue, that may develop first, before you have cancer.

Numerous DDS studies have been conducted but most have focused on treatments for cancer.

The findings, published Feb. 10 in the journal Cancer Cell, raise hopes that treatment strategies that focus on both enzymes simultaneously could help bring molecularly targeted treatments to AML, a common blood cCancer Cell, raise hopes that treatment strategies that focus on both enzymes simultaneously could help bring molecularly targeted treatments to AML, a common blood cancercancer.

«Unique study focuses on combined treatment approach for locally advanced pancreatic cancer.»

The collection contains over 20,000 different samples of Salmonella, with half of the samples housed at the Cancer Research Center where researchers affiliated with MU focus on three areas of cancer research: early detection, targeted treatment and new, effective chemothCancer Research Center where researchers affiliated with MU focus on three areas of cancer research: early detection, targeted treatment and new, effective chemothcancer research: early detection, targeted treatment and new, effective chemotherapy.

From screenings to diagnosis and treatment, our cancer care is available at all seven locations across Greater Houston, so you can focus on healing, surviving and thriving.

Radiation treatment, also known as radiotherapy, destroys cancer by focusing high - energy rays on the cancer cells.

This year's Action Award honorees include global leaders in the fight to end cancer as we know it; a world leader in advancing the emerging field of regenerative medicine and game - changing cell therapy medical treatments; the president of a non-profit group focused on developing cures for chronic, debilitating and fatal diseases; a sickle cell and stem cell advocate and founder / science administrator of the Axis Advocacy; and the founding director of the Institute for Integrated Cell - Material Sciences (iCeMS) at Japan's Kyoto University.

These centers focus the efforts of collaborative groups of researchers on defined areas of inquiry, to accelerate progress toward the development of new treatments and vaccines to prevent and cure type 1 diabetes, cancer and infectious disease.

Every day, more than 30 scientists focus on new research therapies and innovative treatments to attack the fourth most common cancer among men.

The Red and Charline McCombs Institute for the Early Detection and Treatment of Cancer brings together thought leaders in six key areas of biomedical research to focus on molecular - based approaches to cancer diagnosis and tTreatment of Cancer brings together thought leaders in six key areas of biomedical research to focus on molecular - based approaches to cancer diagnosis and treaCancer brings together thought leaders in six key areas of biomedical research to focus on molecular - based approaches to cancer diagnosis and treacancer diagnosis and treatmenttreatment.

Her research focuses on the quality of cancer care in two areas: (1) quality of life for cancer patients undergoing treatment and (2) coordination of care for cancer survivors.

Heidi Simmons decided to focus on cell therapy for treatment of blood cancers like leukemia, lymphoma and myeloma, where healthy cells are infused into patients to replenish those damaged by cancer.

[39] These results underscore the importance of monitoring long - term treatment of CNS metastasis in this subtype of lung cancer, and the importance of focusing on non — WBRT - based treatments to achieve a meaningful response.

He also held several positions of increasing leadership at Praecis Pharmaceuticals, including Director of Cell Biology, where he initiated or contributed to the establishment of numerous research projects focusing on the discovery of novel therapeutics for the treatment of cancer, inflammation, infectious disease, and neurological disorders.

Argos is focused on the treatment of metastatic cancers and chronic infections using a proprietary platform technology that stimulates immune cells with messenger RNA.

Dr Jayaraman, Senior Lecturer in the Institute of Cancer Sciences — part of the Institute of Medical and Dental Sciences at the University of Birmingham, said: «This unique collaboration focuses on the identification of new mechanisms and new targets for treatment.

Much of the research to be presented is focused on immunotherapy, which is seen as the most promising advance in cancer treatment in decades.

Much of my work focuses on communication about the cancer diagnosis, cancer treatment decision - making, and the transition to palliative care, where communication can have a major impact on the care that unfolds at the end of life.

Big Pharma's focus on blockbuster cancer drugs squeezes out research into potential treatments that are more affordable.

There, she used her modeling prowess to solve problems plaguing cancer treatment, focusing on a type of lung cancer, among others.

By focusing on specific plans for treatment, the book is an invaluable resource for the daily care of cancer patients.

Our current efforts relating to our pluripotent stem cell platform are focused on developing AST - OPC1 (hES cell - derived neural cells) for the treatment of spinal cord injury and other neurodegenerative diseases, and AST - VAC2 (hES cell - derived immunotherapy) for cancer.

She is registred to the National Order of Biologists in the province of Palermo; collaboration in research project from 2012 to 2015 at the Department of Biopathology and Biotechnology, University of Palermo, focusing the study on the identification of molecules capable to modulate intracellular metabolic pathways for the prevention and treatment of infectious, tumor and degenerative disease, in collaboration with Prof. Angela Santoni, University of Rome; collaboration in research project in 2011 at the hospital «Villa Sofia Cervello» of Palermo to study methods can cure the genetic defect that causes thalassemia through genetic engineering; she studies different mechanisms of the differentiation and the activation of human gammadelta T cells as effector cells of the immune response against cancer and infectious diseases; she investigates about the identification and development of biomarkers of resistance and susceptibility to Mycobacterium tuberculosis infection; Valentina Orlando has published 13 papers in peer reviewed journals and 3 comunications at national and international congress.

A new multicenter trial focuses on providing precision treatments for rare cancers based on genetics, not tumor site.

Focused on the treatment of cancers and blood disorders, as well as directing chemotherapy care, the hematologists and oncologists at Wake Forest Baptist Health work as part of a team of specialists to provide the best possible care in North Carolina.

His research, including an NIH Clinical and Translational Science Award, focuses on colorectal, liver metastases and pancreatic cancer treatments.

Cancer immunotherapy is focused on the immune system and is often more targeted than conventional cancer treatments such as chemotherapy or radCancer immunotherapy is focused on the immune system and is often more targeted than conventional cancer treatments such as chemotherapy or radcancer treatments such as chemotherapy or radiation